New Alliance Capital

New Alliance Capital

A venture capital firm in China that focuses on high-end manufacturing sectors

New Alliance Capital, also known as 联新资本/ Lianxin Ziben, is a venture capital firm in China that focuses on high-end manufacturing, media, energy, consumer goods, information, recycling, environmental protection technology, advanced agriculture, and modern services industries. Founded in 2008 by Liefeng Qu in Shanghai, China, this company invests in early stage, growth stage and pre-IPO ventures. Its portfolio companies include United Imaging, Shanghai Engineering Cell Therapy, STA Pharma, Thousandaks, Microport, Rapid Medical, Lombard, etc.

New Alliance Capital is still active and as of November 2019, the company made a total of 10 investments. The company’s latest investment was made on Jun 10, 2019. New Alliance Capital had one exit.

Timeline

2008

Founded

Funded Companies

Company
Description
Industry
Website
Location
Sight Diagnostics

Sight is a blood diagnostic company based in Tel Aviv, Israel.

Innoviz is a leading manufacturer of high-performance, solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles.

CF PharmTech is a City of Industry, California-based company.

3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Akane

Investment Team

Li Fei

Investment Team

Liefeng Qu

Founder and partner

Wu Zonghe

Investment Team

Xu Hai

Investment Team

Zhang Nan

Investment Team

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Thousand Oaks Biopharmaceuticals

Banma Kuaipao

CooTek

Innoviz Technologies

ShopEx

Sight Diagnostics

Sight Diagnostics

Wuhan Zebra Express

ZStack

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.